In re Tisdall

87 F.2d 505, 24 C.C.P.A. 900, 1937 CCPA LEXIS 52
CourtCourt of Customs and Patent Appeals
DecidedFebruary 1, 1937
DocketNo. 3751
StatusPublished

This text of 87 F.2d 505 (In re Tisdall) is published on Counsel Stack Legal Research, covering Court of Customs and Patent Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re Tisdall, 87 F.2d 505, 24 C.C.P.A. 900, 1937 CCPA LEXIS 52 (ccpa 1937).

Opinions

LenROOt, Judge,

delivered the opinion of the court:

This appeal brings before us for review a decision of the Board of Appeals of the United States Patent Office, affirming a decision of the examiner rejecting all of the claims of appellant’s application as unpatentable in view of the cited prior art. Eight claims are involved in this appeal, four of which are product claims, the others being process claims. Claims 5, 17, and 22 are illustrative of the claims béfore us and read as follows:

5. A bread comprising shortening as an ingredient, said shortening comprising an oil activated to possess vitamin D properties in a desired potency.
17. A breadstuff comprising shortening as an ingredient, said shortening comprising a relatively small amount of vegetable oil in which has been dissolved a relative concentration of activated ergosterol.
22. A method of making bread which comprises formiing a solution in oil of irradiated ergosterol, combining said solution with the usual ingredients of bread dough, said ingredients being present in the usual proportions except [901]*901that said oil solution replaces an equivalent amount of the usual shortening, said material having such a high vitamin-D potency and being of such nature that its presence in bread dough will in no way change the normal taste, color or consistency of the bread, and baking.

The references cited are :

Hoffman, 1,431,525, October 10, 1922.
Hoffman, 1,579,447, April 6, 1926.
McGroarty, 1,863,277, June 14, 1932.
Steenbock, 1,680,818, August 14, 1928.
Windaus, 1,873,942, August 23, 1932.
Steenbock (British), 314,942, Com. Not Acc.
Johnson (British),-321,992, November 25, 1929.
Elias (British), 266,101.
“Nature,” December 31, 1927, p. 955.
Can. Med. Jour., February, 1931, pp. 210-213.
Biochem. Jour., Yol. 19 (1925), pp. 733-736.

Appellant’s application relates to the introduction of vitamin D into bread, which is accomplished by the use of activated ergosterol as an ingredient, in addition to the usual ingredients employed in the making of bread. The ergosterol is first activated by means of ultra violet rays, and then combined with an oil which is used as a shortening, the amount of shortening ordinarily used in the making of bread being reduced by the amount of oil employed carrying the activated ergosterol.

The statement of the examiner discusses at length the history of vitamin D and its value in the prevention of rickets in the human body. From this, and from the references, it appears that activated ergosterol produces vitamin D in satisfactory quantities.

In appellant’s brief we find a concise statement respecting ergosterol and vitamin D, which is conceded to be correct. It reads as follows:

Ergosterol is found chiefly in fungi, in ergot of rye and in yeast. There are minute traces of ergosterol in the human skin, and the beneficial results of sunlight in the treatment of rickets are apparently due to the activation of these minute traces from the ultra-violet rays of the sun. When ergosterol is exposed to ultra-violet irradiation in the laboratory, it loses its crystalline character and becomes resinous, and this resinous substance is specific in curing rickets, and may be as much as a million times more potent than codliver oil.
In addition to its relationship to the prevention and cure of rickets; vitamin D has an important place in the calcium and phosphorus metabolism of the body, particularly during periods of growth, pregnancy and lactation. It plays an important part in the prevention of dental caries, tetany and osteo-malacia, and the administration of this vitamin increases resistance against disease. But no other vitamin is so sparsely distributed in natural foods as is vitamin D. Codliver oil and egg yolk are the only substances containing appreciable amounts. Milk may contain vitamin D, depending, on the diet [902]*902of the cow, and. varying with the season, but from the nutritional standpoint, milk as a source is negligible. Butter may have traces.

While a large number of references are cited, the Board of Appeals specifically relied only upon the patents to McGroarty and Elias. The examiner was of the opinion that, the medicinal value of vitamin I) being well known at the time of filing appellant’s application, as shown by the references, there would be no invention in incorporating this vitamin into bread, the bread being used as a vehicle for vitamin D, even in the absence of any prior art showing that it had been used in bread. The board did not discuss this ground of rejection. The examiner, however, further rejected the claims upon the ground that the patent to Elias and the patent to McGroarty did teach the use of vitamin D in bread, and in view of that fact and further in view of the cited prior art teaching the beneficial uses of vitamin D, it did not require invention to create the product claimed by appellant or to practice the process disclosed by him.

Appellant’s process is described in the examiner’s statement as follows;

The process comprises mixing flour, water and yeast and then adding thereto an oil and salt solution of irradiated ergosterol. Such oil that is used as a carrier for the irradiated ergosterol replaces an equal amount of shortening; that is, if a pound of oil be used for the ergosterol, one pound less of shortening is emifloyed in the bread recipe, thus the added oil for the ergosterol does not unbalance the shortening-batter ratio. Applicant then bakes the dough in a conventional manner. Bolls, biscuits and similar panary products may be prepared as well as bread.

It is unnecessary to analyze the references other than Elias and McGroarty, for it is clear that the latter are much more pertinent than are the others cited. With respect to the references other than Elias and McGroarty, it is sufficient to say that they disclose the use of vitamin D to be administered in the form of a medicine, the activation of the ordinary ingredients of certain foods, but not of bread, and the activation of ergosterol.

The patent to Elias discloses a process for the production of foodstuffs containing vitamin D. The patent states:

According to the present invention, I have found that the full-food value can be imparted and retained for a reasonably long period to biscuits, bread, cakes and similar preparations by conducting the process of baking in the presence of artificially produced ultra-violet rays, the heating being obtained by one or more sources of both light and radiant heat for which purpose I provide an oven with one or more ultra-violet lamps preferably a quartz mercury vapour lamp, and a series of incandescent luminous burners or other appropriate means for producing heat as well as light and to maintain a temperature of about 90° C. It is even found advantageous to reduce the temperature to some 60° 0. towards the centre of the oven or at the end [903]

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
87 F.2d 505, 24 C.C.P.A. 900, 1937 CCPA LEXIS 52, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-tisdall-ccpa-1937.